LXRX icon

Lexicon Pharmaceuticals
LXRX

Overview Fund Activity

105 hedge funds and large institutions have $280M invested in Lexicon Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 7 closing their positions.

Holders
105
Holders Change
+7
Holders Change %
+7.14%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
38
Reduced
32
Closed
7
Calls
$296K
Puts
$69K
Net Calls
+$227K
Net Calls Change
+$27K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$2.25M
2
Connor, Clark & Lunn Investment Management (CC&L)
2
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$257K
3
PHP
3
Parkman Healthcare Partners
Connecticut
$804K
4
SSA
4
Schonfeld Strategic Advisors
New York
$223K
5
Fisher Asset Management
5
Fisher Asset Management
Washington
$1.38M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$2.57M
2
AQR Capital Management
2
AQR Capital Management
Connecticut
$89.8K
3
Natixis Advisors
3
Natixis Advisors
Massachusetts
$0
4
Group One Trading
4
Group One Trading
Illinois
$46.3K
5
Norges Bank
5
Norges Bank
Norway
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CASC
101
Coppell Advisory Solutions Corp
Texas
$216 +$216 +113 New
CIBC Private Wealth Group
102
CIBC Private Wealth Group
Georgia
$57 – – –
Natixis Advisors
103
Natixis Advisors
Massachusetts
– -$212K -88,411 Closed
Norges Bank
104
Norges Bank
Norway
– -$199K -82,900 Closed
GCP
105
GSA Capital Partners
United Kingdom
– -$170K -71,004 Closed
HF
106
HRT Financial
New York
– -$109K -45,569 Closed
VF
107
Virtu Financial
New York
– -$32K -13,458 Closed
Wells Fargo
108
Wells Fargo
California
– -$2K -761 Closed
1 2 3 4
5